Trials / Unknown
UnknownNCT01674686
The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm
A Prospective, Single-center, Randomized Study to Evaluate the Effect of Sarpogrelate, a Selective Serotonin Receptor Antagonist, and High Dose Statin on the Reduction of Coronary Spasm in the Patients With Variant Angina
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to to evaluate the effect of sarpogrelate, a selective serotonin receptor antagonist, and high dose statin on the reduction of coronary spasm in the patients with variant angina.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sarpogrelate | Sarpogrelate 100mg twice a day |
| DRUG | Atorvastatin | Atorvastatin 80mg daily |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2012-08-29
- Last updated
- 2018-02-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01674686. Inclusion in this directory is not an endorsement.